TrialInternational journal of hematology2012

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.

Yoshitoyo Kagami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.